RNF144B
E3 ubiquitin-protein ligase RNF144B
Also known as: bA528A10.3, IBRDC2, P53RFP, R144B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z419
- Gene
- RNF144B
- Ensembl
- ENSG00000137393
- Chromosome
- 6
- Canonical length
- 303 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Nucleoli,Mitochondria
OverviewNCBI Gene
Enables ubiquitin-protein transferase activity. Involved in negative regulation of apoptotic process and ubiquitin-dependent protein catabolic process. Located in mitochondrial membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
303 residues, UniProt reviewed canonical sequence.
>Q7Z419|RNF144B
1 MGSAGRLHYL AMTAENPTPG DLAPAPLITC KLCLCEQSLD KMTTLQECQC IFCTACLKQY
61 MQLAIREGCG SPITCPDMVC LNHGTLQEAE IACLVPVDQF QLYQRLKFER EVHLDPYRTW
121 CPVADCQTVC PVASSDPGQP VLVECPSCHL KFCSCCKDAW HAEVSCRDSQ PIVLPTEHRA
181 LFGTDAEAPI KQCPVCRVYI ERNEGCAQMM CKNCKHTFCW YCLQNLDNDI FLRHYDKGPC
241 RNKLGHSRAS VMWNRTQVVG ILVGLGIIAL VTSPLLLLAS PCIICCVCKS CRGKKKKHDP
301 STTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RNF144B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 53 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 53 nTPM
- thyroid gland: 38 nTPM
- breast: 27 nTPM
- bone marrow: 23 nTPM
- skin: 20 nTPM
- lung: 18 nTPM
Single-cell type
- neutrophils: 3,934 nCPM
- suprabasal keratinocytes: 1,427 nCPM
- monocytes: 1,203 nCPM
- basal keratinocytes: 705 nCPM
- cdc: 614 nCPM
- macrophages: 522 nCPM
Immune cell
- non-classical monocyte: 72 nTPM
- intermediate monocyte: 39 nTPM
- neutrophil: 37 nTPM
- classical monocyte: 21 nTPM
- plasmacytoid DC: 18 nTPM
- myeloid DC: 13 nTPM
Brain region
- midbrain: 20 nTPM
- medulla oblongata: 19 nTPM
- thalamus: 17 nTPM
- pons: 14 nTPM
- choroid plexus: 13 nTPM
- spinal cord: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.26
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.53
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- negative regulation of apoptotic process
- protein ubiquitination
- ubiquitin-dependent protein catabolic process
Molecular functions
- ubiquitin conjugating enzyme binding
- ubiquitin protein ligase activity
- ubiquitin-protein transferase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RNF144B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RNF144B as an antibody target. Whether an autoantibody or antibody against RNF144B could matter depends on whether native RNF144B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RNF144B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RNF144B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...